State Board of Administration of Florida Retirement System
KITE

State Board of Administration of Florida Retirement System’s Kite Pharma, Inc. KITE Stock Holding History

State Board of Administration of Florida Retirement System’s Portfolio KITE Stock Details KITE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-27,107
Closed -$4.87M – 2451
2017
Q3 		$4.87M Buy
27,107
+2,980
+12% +$415K 0.01% 822
2017
Q2 		$2.5M Buy
24,127
+2,164
+10% +$177K 0.01% 986
2017
Q1 		$1.72M Hold
21,963
– – 0.01% 1137
2016
Q4 		$985K Buy
21,963
+200
+0.9% +$9.81K ﹤0.01% 1455
2016
Q3 		$1.22M Buy
21,763
+880
+4% +$49K ﹤0.01% 1304
2016
Q2 		$1.04M Buy
20,883
+2,862
+16% +$141K ﹤0.01% 1367
2016
Q1 		$827K Buy
18,021
+2,550
+16% +$124K ﹤0.01% 1525
2015
Q4 		$953K Buy
15,471
+4,412
+40% +$311K ﹤0.01% 1497
2015
Q3 		$616K Buy
11,059
+5,627
+104% +$354K ﹤0.01% 1732
2015
Q2 		$331K Buy
+5,432
New +$310K ﹤0.01% 2138

State Board of Administration of Florida Retirement System's KITE Position: Q4 2017 in Review

State Board of Administration of Florida Retirement System sold out of Kite Pharma, Inc. (KITE) in Q4 2017, closing a stake of 27,107 shares — an estimated $4.87M sold.

State Board of Administration of Florida Retirement System first reported a position in KITE in Q2 2015 and held it in 10 quarters. The position peaked at $4.87M in Q3 2017. 0 funds tracked by Wall St. Rank hold KITE as of Q4 2017.

  • State Board of Administration of Florida Retirement System reported no remaining Kite Pharma, Inc. position as of Q4 2017 after selling out during the quarter.
  • State Board of Administration of Florida Retirement System sold 27,107 Kite Pharma, Inc. shares in Q4 2017, an estimated $4.87M.
  • State Board of Administration of Florida Retirement System first reported a position in Kite Pharma, Inc. in Q2 2015 and held it in 10 quarters.
  • State Board of Administration of Florida Retirement System's Kite Pharma, Inc. position peaked at $4.87M in Q3 2017.
  • 0 funds tracked by Wall St. Rank held Kite Pharma, Inc. as of Q4 2017.

Based on State Board of Administration of Florida Retirement System's 13F filing for Q4 2017, filed 1 Feb 2018.